Xtant Medical Holdings (XTNT) Net Cash Flow (2010 - 2025)

Xtant Medical Holdings (XTNT) has 16 years of Net Cash Flow data on file, last reported at $3.5 million in Q3 2025.

• On a quarterly basis, Net Cash Flow rose 121.8% year-over-year to $3.5 million in Q3 2025; TTM through Dec 2025 was $4.4 million, a 874.72% increase from a year earlier, with the FY2024 full-year figure at $447000.0, up 103.06% from the prior year.
• Net Cash Flow for Q3 2025 stood at $3.5 million, up from $1.6 million in the prior quarter.
• Over the last five years, Net Cash Flow for XTNT reached as high as $16.3 million in Q1 2021 and fell as low as -$15.1 million in Q1 2023.
• Historically, Net Cash Flow has averaged $440105.3 across 5 years, with a median of -$124000.0 in 2022.
• Across the five-year window, Net Cash Flow soared 1379.3% in 2022 and slumped 966.17% in 2023, its largest moves.
• Year by year, Net Cash Flow stood at -$227000.0 in 2021, then surged by 1379.3% to $2.9 million in 2022, then sank by 199.97% to -$2.9 million in 2023, then jumped by 73.96% to -$756000.0 in 2024, then surged by 565.61% to $3.5 million in 2025.
• Per Business Quant data, the three most recent Net Cash Flow figures were $3.5 million in Q3 2025, $1.6 million in Q2 2025, and -$784000.0 in Q1 2025.